CDMO News
C3i Becomes First Canadian CDMO with Cell Therapy License
C3i Center Inc. has achieved a significant milestone by obtaining a Drug Establishment License (DEL) from Health Canada, authorizing the commercial production of cell therapies. This approval makes C3i the first CDMO in Canada to reach this achievement. Following an
24 June 2024
Stay ahead of trends and best practices
